FOCUp

Follow the Money · Australia

Cancer Australia

Health, Disability and Ageing portfolio

$50.5M

$50,488,000 across 1 programs, 2026-27

Source: Portfolio Budget Statements 2026-27, 2026-27 PBS Program Expenses Line Items - Updated 2026-06-18 (w. Corrigenda). Retrieved 25 September 2026.

Administered

$34.6M

Money it hands out on the government's behalf — grants, benefits, subsidies.

Departmental

$15.9M

What it costs to run: staff, property, suppliers.

Contracts published

107

$17.8M in total

Programs

Each line is a program in the budget papers, with what it is given. The category is FOCUp's, mapped from the published program name; a blank means no rule matched it plainly, which is recorded rather than guessed.

ProgramCategoryAdministeredDepartmentalTotal

Program 1.1: Improved Cancer Control

Outcome 1: Minimised impacts of cancer, including through national leadership in cancer control with targeted research and clinical trials; evidence informed clinical practice; strengthened national data capacity; community and consumer information and support

2026-27 PBS Cancer · retrieved 25 September 2026

Not classified$34.6M$15.9M$50.5M100.0%

Largest contracts

The 25 largest of 107. A contract notice is the value of an agreement over its whole term, not money spent in a year, so these are never added to the budget figures.

SupplierForTermValue

Australian Institute of Health and Welfare

Schedule 1 under the MoU between Cancer Australia and the AIHW. The AIHW will deliver projects to support the development of cancer and screening data linkage infrastructure and facilitate the improvement of metastatic data.CN41772242 June 2024 to 29 June 2028$5.0M

Evolve FM Ptd Lty

Evolve FM Rent and POE. Transition out and in signed by the DOF- Pckage 4 for Cancer AustraliaCN426273430 June 2025 to 29 June 2029$3.0M

Nous Group Pty Ltd

Contract with Nous Group Pty Ltd and partner Curijo to provide services to implement the Monitoring and Evaluation Framework for the Partnerships for culturally safe cancer care grant program.CN423724618 March 2026 to 29 June 2028$693.6K

University of Technology Sydney

Cancer Australia has executed a contract with the University of Technology, as represented by the Cancer Quality of Life Expert Service Team (CQUEST), as the supplier for the Quality of Life (QoL) National Technical Service (NTS). CQUEST will provide Multi-site Collaborative Cancer Clinical Trials Groups with expert advice and support for the inclusion of Health-related Quality of Life (HRQOL) and Patient Reported Outcomes (PRO) measures and/or sub-studies into investigator-initiated and industry-independent cancer clinical trial concepts and protocols for the period 1 July 2025 to 30 June 2027.CN416587530 June 2025 to 29 June 2027$668.3K

University of Technology Sydney

Cancer Australia has executed a contract with the University of Technology, as represented by the Centre for Health Economics Research and Evaluation (CHERE) as the supplier for the Health- and Pharmaco-economics (HE) National Technical Service (NTS). CHERE will provide Multi-site Collaborative Cancer Clinical Trials Groups with expert advice and support for the inclusion of HE measures/sub-studies into investigator-initiated and industry-independent cancer clinical trial concepts and protocols for the period 1 July 2025 to 30 June 2027.CN416587630 June 2025 to 29 June 2027$656.7K

The University of Melbourne

Procurement of services to undertake an economic evaluation of the Prostate Cancer Foundation of Australia's (PCFA) Clinical Guidelines for the Early Detection of Prostate Cancer.CN423213330 March 2026 to 29 October 2026$506.4K

Jacinta Elston Pty Ltd

Provision of expertise on the development and implementation of Cancer Australia policies and programs, with a focus on improving outcomes for Aboriginal and Torres Strait Islander peoples affected by cancerCN419401222 July 2025 to 29 June 2027$408.4K

F1 Solutions

Development, ongoing management and platform license for grant management software for Cancer. The Support Agreement has been incorporated into this contractCN418696514 February 2022 to 29 June 2026$366.2K

Alison Evans Consulting

Procurement of supplier to review and update the Optimal Care Pathway (OCP) templates to align with key policies, reflect current evidence and best practice and improve accessibility and functionality for clinicians.CN420788917 November 2025 to 29 September 2027$261.6K

Evolve FM Ptd Lty

Evolve FM as Head Contractor will manage a partial refurbishment of existing Fit-out of Level 9, 5 Farrell Place, CanberraCN420789128 October 2025 to 27 February 2026$254.2K

Cancer Council Queensland

Services to enhance national collection and reporting of childhood and adolescent cancer data in AustraliaCN427835520 August 2026 to 29 August 2027$242.0K

Cancer Council Queensland

Deliver an improved and updated collection of population-level data for childhood cancers in Australia, including updated reporting on non-stage prognostic indicators and stage at diagnosis data, for reporting on the National Cancer Control Indicators (NCCI) websiteCN418702911 August 2025 to 11 June 2026$225.1K

Children's Cancer CoLab

To facilitate development of an OCP for children with cancerCN424547427 April 2026 to 29 April 2028$220.0K

Congress of Aboriginal and Torres Strait Islander Nurses and Midwives (CATSINaM)

Procurement of services to build the Aboriginal and Torres Strait Islander cancer care nursing workforceCN424999130 March 2026 to 30 March 2027$208.2K

The Kids Research Institute

Procurement of services to map cancer-specific genomics initiatives and priorities for Aboriginal and Torres Strait Islander peopleCN42245681 February 2026 to 1 December 2026$203.5K

PreviousNext Pty Ltd

The supplier will provide ongoing managed services to support Cancer Australia’s corporate websites.CN41781232 July 2025 to 9 January 2027$198.8K

Murawin Pty Ltd

Contract with Murawin Pty Ltd to provide services to establish a national Grant Collaborative Community in support of the Partnerships for culturally safe cancer care grant program.CN422170013 January 2026 to 29 June 2027$198.0K

Curtin University

Funding to support the operation of the Lung Cancer Clinical Quality Data Platform (LUCAP) to ensure ongoing data completeness, linkage, and impact evaluation of lung cancer care, which directly supports Australia’s national cancer control priorities, including the National Lung Cancer Screening Program.CN424992324 May 2026 to 29 September 2027$192.5K

ORIMA Research Pty Ltd

Cancer Australia has engaged ORIMA Research to deliver the fourth national audit of cancer research funding and key funding drivers report, by undertaking an audit of cancer research funding across the period of 2021-2023 combined with a desktop review and analysis of the key drivers for cancer research patterns and funding over this period.CN42272792 March 2026 to 13 August 2026$190.8K

Universal McCann

The contract engages UM to deliver a targeted, national advertising campaign to promote the National Lung Cancer Screening Program to general practitioners and health professionals through digital, media, and out-of-home channels. Payments are made monthly in arrears based on media delivered under the approved Media Booking Authority, in line with whole-of-government media arrangements.CN424546520 May 2026 to 29 June 2026$172.6K

Inherited Cancer Australia

Procurement of services to develop targeted genomics health literacy resources for consumers with or at high risk of inherited cancerCN420484129 October 2025 to 29 June 2026$170.2K

Sustainable Health System Solutions Pty Ltd (Professor Adam Elshaug)

Services to support the 2-year Evaluation of the Australian Cancer PlanCN42089079 November 2025 to 9 May 2026$160.8K

Concur Holdings

SAP Concur Software Subscription 01/07/2022-30/09/2026CN426218430 June 2022 to 29 September 2026$156.3K

Link Web Services Pty Ltd T/A Link Digital

Website support and maintenance for the financial year 25/26 and 26/27 to various Cancer Australia websites.CN417866830 June 2025 to 9 January 2027$142.2K

Cancer Council Queensland

Provision of services to update the Australian Cancer Atlas with cancer risk factor and screening and testing data.CN425229510 June 2026 to 29 June 2027$141.9K
The whole register